Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myomo Inc. Common Stock (NY: MYO )

6.450 +0.010 (+0.16%)
Streaming Delayed Price Updated: 2:30 PM EST, Jan 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Myomo Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Why Nordstrom Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Alset Capital Acquisition Corp. (NASDAQ: ACAX) shares climbed 66.2% to $12.93. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares gained 57.6% to $1.19 in pre-market trading after the company announced the purchase of shares by company officers. 
Via Benzinga
Myomo: Q1 Earnings Insights
Via Benzinga
Myomo's Return On Capital Employed Insights
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to close out this week of trading with an overview of the biggest pre-market stock movers to watch Friday morning! 
Via InvestorPlace
Myomo Announces Pricing of $4.4 Million Public Offering
From Myomo, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Myomo, Inc. Announces Proposed Public Offering
From Myomo, Inc.
Via Business Wire
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
From Myomo, Inc.
Via Business Wire
Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement
From Myomo, Inc.
Via Business Wire
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
From Myomo, Inc.
Via Business Wire
Myomo to Report Second Quarter Financial Results on August 9, 2023
From Myomo, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Centers for Medicare and Medicaid Services Accepts Myomo’s Application to Classify the MyoPro® as a Brace
From Myomo, Inc.
Via Business Wire
Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
From Myomo, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
Via Benzinga
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
From Myomo, Inc.
Via Business Wire
Myomo to Report First Quarter Financial Results on May 10, 2023
From Myomo, Inc.
Via Business Wire
Myomo Receives Technology License Fee Payment from China Joint Venture Company
From Myomo, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning! 
Via InvestorPlace
Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout
Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies. 
Via Benzinga
Myomo Makes NYSE American Section 610(b) Public Announcement
From Myomo, Inc.
Via Business Wire
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
From Myomo, Inc.
Via Business Wire
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.